ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

INHX Inhibitex, Inc. (MM)

26.00
0.00 (0.00%)
23 Jan 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Inhibitex, Inc. (MM) NASDAQ:INHX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 26.00 0 00:00:00

The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Inhibitex, I...

13/01/2012 7:07pm

Marketwired


Inhibitex, Inc. (MM) (NASDAQ:INHX)
Historical Stock Chart


From Jan 2020 to Jan 2025

Click Here for more Inhibitex, Inc. (MM) Charts.

Levi & Korsinsky notifies investors of Inhibitex, Inc. ("Inhibitex" or the "Company") (NASDAQ: INHX) of claims of breaches of fiduciary duty and other violations of state law against the board of directors of the Company in connection with the sale of the Company to Bristol-Myers Squibb Co. (NYSE: BMY). Under the terms of the transaction, Inhibitex shareholders will receive $26 per share of Inhibitex stock they own. The transaction has a total approximate value of $2.5 billion. Shareholders with beneficial ownership of approximately 17% of Inhibitex common stock have already entered into agreements with Bristol-Myers to support the transaction and to tender their shares in the tender offer. A complaint was filed in Delaware state court.

Click here to learn how to join the action: http://zlk.9nl.com/inhibitex-inhx, or call: 877-363-5972.

The claims concern whether the Inhibitex Board of Directors breached their fiduciary duties to Inhibitex stockholders by failing to adequately shop the Company before entering into this transaction and whether Bristol-Myers Squibb Co. is underpaying for Inhibitex shares, thus unlawfully harming Inhibitex stockholders.

If you own common stock in Inhibitex and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or http://www.zlk.com/inhibitex-inhx.html.

Levi & Korsinsky has extensive expertise in prosecuting investor securities litigation involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT: Levi & Korsinsky, LLP Joseph Levi, Esq. Eduard Korsinsky, Esq. 30 Broad Street - 15th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com

1 Year Inhibitex, Inc. (MM) Chart

1 Year Inhibitex, Inc. (MM) Chart

1 Month Inhibitex, Inc. (MM) Chart

1 Month Inhibitex, Inc. (MM) Chart

Your Recent History

Delayed Upgrade Clock